Brief: Sprint Bioscience Q2 Operating Loss Widens To SEK 14.7 Million

Sprint Bioscience AB

13/08/2021 06:35

Aug 13 (Reuters) - Sprint Bioscience AB  SPRINT.ST :
    * Q2 NET SALES SEK 0 MILLION VERSUS SEK 5.8 MILLION YEAR AGO
    * Q2 OPERATING RESULT SEK -14,7 (-10,1) MILLION

Source text for Eikon:  ID:nWkrntXgT 
Further company coverage:  SPRINT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))